Aemetis (AMTX) Cash & Equivalents (2010 - 2026)

Aemetis' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $4.8 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 861.32% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 861.32% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 444.99% from the prior year.
• Cash & Equivalents declined to $4.8 million in Q1 2026 per AMTX's latest filing, from $4.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $5.6 million in Q3 2025 and bottomed at $234000.0 in Q2 2024.
• The 5-year median for Cash & Equivalents is $3.5 million (2023), against an average of $2.8 million.
• Across the five-year window, Cash & Equivalents slumped 96.07% in 2022 and soared 1786.49% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $4.3 million in 2022, then slumped by 38.16% to $2.7 million in 2023, then tumbled by 66.33% to $898000.0 in 2024, then jumped by 444.99% to $4.9 million in 2025, then declined by 1.98% to $4.8 million in 2026.
• Per Business Quant, the three latest AMTX Cash & Equivalents figures stand at $4.8 million (Q1 2026), $4.9 million (Q4 2025), and $5.6 million (Q3 2025).